Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab
Clinical trial NCT01213329 · TERMINATED
Trial details
- NCT number
- NCT01213329
- Sponsor
- Northwestern University
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2009-04-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.